BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 12232053)

  • 21. DNA damage-induced MDMX degradation is mediated by MDM2.
    Kawai H; Wiederschain D; Kitao H; Stuart J; Tsai KK; Yuan ZM
    J Biol Chem; 2003 Nov; 278(46):45946-53. PubMed ID: 12963717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
    Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
    J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability and ubiquitination of the tumor suppressor protein p53.
    Jardine LJ; Maki CG
    Methods Mol Biol; 2003; 223():27-38. PubMed ID: 12777718
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.
    Itahana K; Bhat KP; Jin A; Itahana Y; Hawke D; Kobayashi R; Zhang Y
    Mol Cell; 2003 Nov; 12(5):1151-64. PubMed ID: 14636574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoubiquitination: the signal for p53 nuclear export?
    Brooks CL; Li M; Gu W
    Cell Cycle; 2004 Apr; 3(4):436-8. PubMed ID: 14976431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of p53 by Mdm2: fate is in the numbers.
    Shmueli A; Oren M
    Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
    Heessen S; Leonchiks A; Issaeva N; Sharipo A; Selivanova G; Masucci MG; Dantuma NP
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1532-7. PubMed ID: 11805282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.
    Ahn HJ; Kim KS; Shin KW; Lim KH; Kim JO; Lee JY; Kim J; Park JH; Yang KM; Baek KH; Ko JJ; Park KS
    Oncotarget; 2015 Dec; 6(42):44523-37. PubMed ID: 26540344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
    J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes.
    Kashuba E; Mattsson K; Klein G; Szekely L
    Mol Cancer; 2003 Mar; 2():18. PubMed ID: 12685933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response.
    Lyakhovich A; Shekhar MP
    Mol Cell Biol; 2003 Apr; 23(7):2463-75. PubMed ID: 12640129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
    Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
    J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53.
    Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
    Biochem Biophys Res Commun; 2010 Oct; 400(4):649-54. PubMed ID: 20807506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.
    Blagosklonny MV
    Oncogene; 2001 Jan; 20(3):395-8. PubMed ID: 11313969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
    Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
    Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.